© 2021 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2021 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
July 15, 2019
One expert weighs the benefits and drawbacks of expanding clinical trials to be more inclusive and reflective of the general patient population with cancer.
‘Promising Times’ for Patients With CLL
PARP Inhibitors Help Ovarian Cancer Survivors Live Longer – and Better – Without Disease Progression
When Cancer Becomes a Liability in the Relationship
FDA Approves Tecentriq for Pretreated NSCLC